The Efficacy of Telitacicept in the Treatment of Patients with Systemic Lupus Erythematosus Combined with Antiphospholipid Syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Efficacy of Telitacicept in the Treatment of Patients with Systemic Lupus Erythematosus Combined with Antiphospholipid Syndrome

Published:2024 Issue:05 Volume:14 Page:1648-1661
ISSN:2161-8712
Container-title:Advances in Clinical Medicine
language:
Short-container-title:ACM

Author:

盖镱

Publisher

Hans Publishers

Reference44 articles.

1. 沈田, 吴小川. 系统性红斑狼疮: 从发病机制到新型靶向治疗[J]. 协和医学杂志, 2023, 14(2): 234-240.

2. Potential Use of Janus Kinase Inhibitors in the Treatment of Systemic Lupus Erythematosus

3. 中华医学会风湿病学分会, 国家皮肤与免疫疾病临床医学研究中心, 中国系统性红斑狼疮研究协作组. 2020中国系统性红斑狼疮诊疗指南[J]. 中华内科杂志, 2020, 59(3): 172-185.

4. Malignancies among newly diagnosed systemic lupus erythematosus patients and their survival

5. Evaluation of acquired and hereditary risk factors for the development of thromboembolism in patients with systemic lupus erythematosus

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP